Dr. Rashmi Angadi
× About Services Specializations Gallery Blogs
Contact Us

Role of ⁶⁸Ga-FAPI PET-CT in Follow-Up Assessment of Oesophagogastric Junction Cancer: A Case Report

Role of ⁶⁸Ga-FAPI PET-CT in Follow-Up Assessment of Oesophagogastric Junction Cancer: A Case Report

Published

Cancers of the oesophagogastric junction (OGJ) and proximal stomach are aggressive malignancies where accurate post-treatment assessment is critical for long-term outcomes. Conventional imaging may fail to differentiate residual disease from post-treatment changes.
⁶⁸Ga-FAPI PET-CT, a novel molecular imaging technique targeting cancer-associated fibroblasts, offers superior tumor visualization with low background uptake, making it highly effective in therapy response evaluation.

This case highlights the clinical value of ⁶⁸Ga-FAPI PET-CT in post-chemoradiation follow-up of OGJ carcinoma 

 

Case Presentation

Patient: 35-year-old female

Diagnosis: Carcinoma of the oesophagogastric junction and proximal stomach

Referring Oncologist: Dr. Vinay Gadigi (MCh – Surgical Oncology)

Treatment History: Completed chemoradiation in November 2025

Clinical Scenario: Follow-up evaluation; baseline PET-CT not performed

Prior Imaging: CT scan dated 03/10/2025 for comparison

 

Imaging Technique

 

A whole-body ⁶⁸Ga-FAPI-04 PET-CT scan was performed using a digital time-of-flight PET-CT scanner with IV contrast. Images were acquired 30 minutes post-tracer injection, allowing high-resolution metabolic and anatomical correlation.

 

PET-CT Findings

 

The scan revealed:

Focal mild tracer uptake with minimal wall thickening along the proximal lesser curvature of the stomach (SUVmax 4.8), significantly reduced in size compared to prior CT findings

Mild tracer-avid subcentimetric lymph nodes in the porta hepatis, coeliac axis, aortocaval, and para-aortic regions—suggestive of residual nodal disease

No evidence of distant metastases to lungs, liver, bones, or brain

 

Clinical Impact

The scan confirmed partial metabolic response after chemoradiation

Helped distinguish residual disease from post-therapy fibrosis

Provided critical guidance for further oncologic management and surveillance

Avoided unnecessary invasive procedures due to precise molecular assessment

 

Why ⁶⁸Ga-FAPI PET-CT Matters

Compared to FDG PET-CT, FAPI imaging offers:

Superior lesion-to-background contrast

Minimal physiological uptake in bowel and liver

Improved detection of fibroblast-rich tumors such as gastric and OGJ cancers

This makes it an ideal modality for response assessment and restaging.

 

Expertise at NeuMoD Digital PET-CT, Hubli

At NeuMoD Digital PET-CT & Molecular Theranostics, Hubli, we provide:

Advanced FAPI PET-CT imaging

Prompt appointments without delays

Compassionate, patient-centric cancer care

Accurate follow-up imaging to guide precision oncology

 

Conclusion

This case demonstrates the pivotal role of ⁶⁸Ga-FAPI PET-CT in post-treatment evaluation of oesophagogastric junction cancer. By accurately identifying residual disease and excluding distant metastases, FAPI PET-CT enables confident clinical decision-making and personalized patient care.

 

 

Tags : 68Ga FAPI PET CT, oesophagogastric junction cancer, gastric cancer PET CT, FAPI PET CT India, cancer follow up PET CT, molecular imaging oncology, PET CT Hubli, nuclear medicine Hubli, post chemoradiation assessment, theranostics India,
Emergency